Anti-beta 2 Adrenergic Receptor antibody [EPR707(N)],Abcam,AB182136

Anti-beta 2 Adrenergic Receptor antibody [EPR707(N)] (ab182136) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in IHC-Fr, IHC-P, WB in human, mouse, rat samples. Anti-beta 2 Adrenergic Receptor antibody [EPR707(N)] (ab182136) has been cited over 59 times in peer reviewed journals and is trusted by the scientific community. Abcam's high quality manufacturing and validation processes ensure Anti-beta 2 Adrenergic Receptor antibody [EPR707(N)] (ab182136) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. Anti-beta 2 Adrenergic Receptor antibody [EPR707(N)] (ab182136) has 5 independent reviews from customers. Anti-beta 2 Adrenergic Receptor antibody [EPR707(N)] (ab182136) specifically detects beta 2 Adrenergic Receptor (UniProt ID: P07550; Molecular weight: 46kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL). Conjugation-ready, carrier free format available for antibody clone EPR707(N) - ab213651 . Antibody clone EPR707(N) is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 647, Alexa Fluor® 488, Alexa Fluor® 594, Alexa Fluor® 568, Alexa Fluor® 555, Alexa Fluor® 750 ( ab225294 , ab225295 , ab311788 , ab313069 , ab313266 , ab321260 ). Beta-2 adrenergic receptor (ß2-AR) also known as ADRB2 plays a significant role in immuno-oncology by modulating the immune response and influencing tumor progression. Beta-2 adrenergic receptor signaling can affect both innate and adaptive immune cells, impacting their activation, proliferation, and cytokine production. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .